ABSTRACT
Objective: To investigate the economic burden of bacillus Calmette-Guérin (BCG) lymphadenitis in Shandong Province. Methods: From May 2011 to December 2019, 304 patients applying for the province-level compensation of BCG lymphadenitis was selected from Shandong Province in this study. The basic situation, vaccination, outpatient (inpatient) records, cost and relevant information of those patients were collected to calculate the direct economic burden (including direct medical costs and direct non-medical costs), indirect economic burden and total economic burden. Comparison of the difference of economic burden of cases with different characteristics was taken. Results: The M(Q1,Q3) of age of BCG lymphadenitis patients was 3 (2, 4) months, among which 239 cases (78.6%) were male, 71 cases (23.4%) had lymphadenopathy, and 227 cases (74.7%) underwent surgery.The number of outpatient only, inpatient only and outpatient then inpatient was 25.7% (78 cases), 7.2% (22 cases) and 67.1% (204 cases), respectively. The M(Q1,Q3) of direct, indirect and total economic burden of single case after discount was 9 910 (5 713, 16 074), 2 081 (1 547, 3 122) and 12 262 (7 694, 18 571) yuan, respectively.The direct medical expenses accounted for 89.4% of the direct economic burden, the direct economic burden accounted for 84.9% of the total economic burden, the total economic burden of 80.0% cases accounted for only about 20.0% of the compensation amount, and the total economic burden of only 2.3% cases accounted for more than 60.0% of the compensation amount.The direct, indirect and total economic burden of patients with inpatient only and outpatient then inpatient was higher than that of patients with outpatient only; the direct, indirect and total economic burden of patients with operation was higher than that of patients with non-operation; the direct and total economic burden of patients with unulcerated lymph node was higher than that of patients with ulcerated lymph node(all P values<0.05). Conclusion: The economic burden of BCG lymphadenitis cases in Shandong Province is influenced by the mode of diagnosis and treatment, with direct medical expenses as the predominant component.
Subject(s)
BCG Vaccine , Lymphadenitis , Cost of Illness , Financial Stress , Humans , Infant , Lymphadenitis/epidemiology , Male , VaccinationABSTRACT
Mortality data obtained from the Health Statistics Office of the Ministry of Health, People's Republic of China (PRC), were compared to data for other countries taken from the World Health Statistics Annual. The crude death rate for coronary heart disease (CHD) in China in 1984 is estimated to be about one-tenth of that for North America and Australia. However, a high stroke to CHD ratio of about 5.0 was observed in China. The age-standardized CHD mortality rates were significantly higher for Beijing in north China than for Shanghai and Guangzhou in the south, and for urban than rural populations in all years from 1976 to 1986. Data on hospital admissions and autopsy material provide evidence for an increase in CHD incidence and prevalence in the last three to four decades. A low mean serum total cholesterol, related to a low habitual dietary intake of fat and cholesterol, is considered to be the main cause underlying low CHD mortality rates in China.